HEADER LIGASE/DNA 05-MAY-08 2ZO0 TITLE MOUSE NP95 SRA DOMAIN DNA SPECIFIC COMPLEX 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE UHRF1; COMPND 3 CHAIN: B; COMPND 4 FRAGMENT: SRA DOMAIN, RESIDUES 419-628; COMPND 5 SYNONYM: UBIQUITIN-LIKE PHD AND RING FINGER DOMAIN-CONTAINING PROTEIN COMPND 6 1, UBIQUITIN-LIKE-CONTAINING PHD AND RING FINGER DOMAINS PROTEIN 1, COMPND 7 NUCLEAR ZINC FINGER PROTEIN NP95, NUCLEAR PROTEIN 95; COMPND 8 EC: 6.3.2.-; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: DNA (5'- COMPND 12 D(*DTP*DCP*DCP*DAP*DTP*DGP*DCP*DGP*DCP*DTP*DGP*DAP*DC)-3'); COMPND 13 CHAIN: D; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: 12 BASE PAIR DNA DUPLEX; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: DNA (5'-D(*DGP*DTP*DCP*DAP*DGP*(5CM) COMPND 18 P*DGP*DCP*DAP*DAP*DTP*DGP*DG)-3'); COMPND 19 CHAIN: E; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: 12 BASE PAIR DNA DUPLEX SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: NP95; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-GOLD CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PXC666; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES KEYWDS BASE FLIPPING, CELL CYCLE, DEVELOPMENTAL PROTEIN, DNA DAMAGE, DNA KEYWDS 2 REPAIR, DNA-BINDING, LIGASE, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, KEYWDS 3 TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, UBL KEYWDS 4 CONJUGATION PATHWAY, ZINC, ZINC-FINGER, LIGASE-DNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.HASHIMOTO,J.R.HORTON,X.CHENG REVDAT 4 01-NOV-23 2ZO0 1 DBREF SEQADV LINK REVDAT 3 24-FEB-09 2ZO0 1 VERSN REVDAT 2 14-OCT-08 2ZO0 1 JRNL REVDAT 1 09-SEP-08 2ZO0 0 JRNL AUTH H.HASHIMOTO,J.R.HORTON,X.ZHANG,M.BOSTICK,S.E.JACOBSEN, JRNL AUTH 2 X.CHENG JRNL TITL THE SRA DOMAIN OF UHRF1 FLIPS 5-METHYLCYTOSINE OUT OF THE JRNL TITL 2 DNA HELIX JRNL REF NATURE V. 455 826 2008 JRNL REFN ISSN 0028-0836 JRNL PMID 18772888 JRNL DOI 10.1038/NATURE07280 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 708338.010 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.1 REMARK 3 NUMBER OF REFLECTIONS : 18627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 897 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.27 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 57.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1114 REMARK 3 BIN R VALUE (WORKING SET) : 0.3670 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 61 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.048 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1630 REMARK 3 NUCLEIC ACID ATOMS : 519 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 42 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -36.42000 REMARK 3 B22 (A**2) : 30.56000 REMARK 3 B33 (A**2) : 5.86000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.40 REMARK 3 LOW RESOLUTION CUTOFF (A) : 35.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.300 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.120 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.050 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 53.07 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE DENSITY FOR THE NUCLEOTIDE AT REMARK 3 POSITION 9 IN CHAIN E INDICATED AN EXTRAHELICAL CONFORMATION REMARK 3 (E429) AS WELL AS AN INTRAHELICAL CONFORMATION (E430). THE REMARK 3 DEPOSITORS MADE A MODEL AS IF AN ADDITIONAL NUCLEOTIDE A10 WAS REMARK 3 INSERTED. REMARK 4 REMARK 4 2ZO0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000028208. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19727 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 29.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : 10.40 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3BI7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% (V/V) POLYETHYLENE GLYCOL 3350, REMARK 280 0.4M NACL, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.99100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.47800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.50400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.47800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.99100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.50400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG B 626 REMARK 465 LYS B 627 REMARK 465 ARG B 628 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 495 CG CD CE NZ REMARK 470 LYS B 547 CG CD CE NZ REMARK 470 GLU B 613 CG CD OE1 OE2 REMARK 470 GLU B 617 CG CD OE1 OE2 REMARK 470 LYS B 622 CG CD CE NZ REMARK 470 GLU B 623 CG CD OE1 OE2 REMARK 470 DT D 401 N1 C2 O2 N3 C4 O4 C5 REMARK 470 DT D 401 C7 C6 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 460 -61.40 -133.65 REMARK 500 ASN B 508 -122.29 52.66 REMARK 500 ASP B 530 80.88 81.33 REMARK 500 HIS B 548 23.90 -142.47 REMARK 500 GLU B 623 45.75 -77.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ZO1 RELATED DB: PDB REMARK 900 NP95 SRA DOMAIN DNA SPECIFIC COMPLEX 2 REMARK 900 RELATED ID: 2ZO2 RELATED DB: PDB REMARK 900 NP95 SRA DOMAIN NON-SPECIFIC DNA COMPLEX DBREF 2ZO0 B 419 628 UNP Q8VDF2 UHRF1_MOUSE 419 628 DBREF 2ZO0 D 401 413 PDB 2ZO0 2ZO0 401 413 DBREF 2ZO0 E 421 433 PDB 2ZO0 2ZO0 421 433 SEQADV 2ZO0 HIS B 417 UNP Q8VDF2 EXPRESSION TAG SEQADV 2ZO0 MET B 418 UNP Q8VDF2 EXPRESSION TAG SEQRES 1 B 212 HIS MET PRO ALA ASN HIS PHE GLY PRO ILE PRO GLY VAL SEQRES 2 B 212 PRO VAL GLY THR MET TRP ARG PHE ARG VAL GLN VAL SER SEQRES 3 B 212 GLU SER GLY VAL HIS ARG PRO HIS VAL ALA GLY ILE HIS SEQRES 4 B 212 GLY ARG SER ASN ASP GLY ALA TYR SER LEU VAL LEU ALA SEQRES 5 B 212 GLY GLY TYR GLU ASP ASP VAL ASP ASN GLY ASN TYR PHE SEQRES 6 B 212 THR TYR THR GLY SER GLY GLY ARG ASP LEU SER GLY ASN SEQRES 7 B 212 LYS ARG THR ALA GLY GLN SER SER ASP GLN LYS LEU THR SEQRES 8 B 212 ASN ASN ASN ARG ALA LEU ALA LEU ASN CYS HIS SER PRO SEQRES 9 B 212 ILE ASN GLU LYS GLY ALA GLU ALA GLU ASP TRP ARG GLN SEQRES 10 B 212 GLY LYS PRO VAL ARG VAL VAL ARG ASN MET LYS GLY GLY SEQRES 11 B 212 LYS HIS SER LYS TYR ALA PRO ALA GLU GLY ASN ARG TYR SEQRES 12 B 212 ASP GLY ILE TYR LYS VAL VAL LYS TYR TRP PRO GLU ARG SEQRES 13 B 212 GLY LYS SER GLY PHE LEU VAL TRP ARG TYR LEU LEU ARG SEQRES 14 B 212 ARG ASP ASP THR GLU PRO GLU PRO TRP THR ARG GLU GLY SEQRES 15 B 212 LYS ASP ARG THR ARG GLN LEU GLY LEU THR MET GLN TYR SEQRES 16 B 212 PRO GLU GLY TYR LEU GLU ALA LEU ALA ASN LYS GLU LYS SEQRES 17 B 212 SER ARG LYS ARG SEQRES 1 D 13 DT DC DC DA DT DG DC DG DC DT DG DA DC SEQRES 1 E 13 DG DT DC DA DG 5CM DG DC DA DA DT DG DG MODRES 2ZO0 5CM E 426 DC HET 5CM E 426 20 HETNAM 5CM 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE FORMUL 3 5CM C10 H16 N3 O7 P FORMUL 4 HOH *42(H2 O) HELIX 1 1 PHE B 437 SER B 444 1 8 HELIX 2 2 ASN B 508 CYS B 517 1 10 HELIX 3 3 ASP B 530 GLY B 534 5 5 HELIX 4 4 LYS B 544 HIS B 548 5 5 HELIX 5 5 THR B 595 LEU B 605 1 11 HELIX 6 6 GLY B 614 GLU B 623 1 10 SHEET 1 A 5 MET B 434 TRP B 435 0 SHEET 2 A 5 ASN B 557 ARG B 572 -1 O ASN B 557 N TRP B 435 SHEET 3 A 5 LEU B 578 ARG B 586 -1 O LEU B 583 N LYS B 567 SHEET 4 A 5 TYR B 480 THR B 484 -1 N PHE B 481 O LEU B 584 SHEET 5 A 5 VAL B 475 ASP B 476 -1 N VAL B 475 O THR B 482 SHEET 1 B 5 ILE B 454 ARG B 457 0 SHEET 2 B 5 GLY B 461 LEU B 467 -1 O SER B 464 N HIS B 455 SHEET 3 B 5 VAL B 537 ASN B 542 1 O ASN B 542 N LEU B 467 SHEET 4 B 5 ASN B 557 ARG B 572 -1 O ARG B 558 N ARG B 541 SHEET 5 B 5 ALA B 526 GLU B 527 -1 N ALA B 526 O TYR B 568 LINK O3' DG E 425 P 5CM E 426 1555 1555 1.61 LINK O3' 5CM E 426 P DG E 427 1555 1555 1.62 CRYST1 61.982 69.008 92.956 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016134 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014491 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010758 0.00000